Estradiol/dydrogesterone
Combination drug From Wikipedia, the free encyclopedia
Estradiol/dydrogesterone (E2/DYD), sold under the brand name Femoston among others, is a combination of estradiol (E2), an estrogen, and dydrogesterone (DYD), a progestin, which is used in menopausal hormone therapy, specifically to treat and prevent hot flashes and osteoporosis, in postmenopausal women.[2][3][4] It is taken by mouth and contains 0.5, 1, or 2 mg E2 and 2.5, 5, 10, or 20 mg DYD per tablet.[5][6][7] The medication is marketed widely throughout the world.[8] It is not available in the United States or Canada.[8]
Estradiol | |
 Dydrogesterone | |
| Combination of | |
|---|---|
| Estradiol | Estrogen |
| Dydrogesterone | Progestogen; Progestin |
| Clinical data | |
| Trade names | Femoston, Climaston, Femaston |
| Other names | E2/DYD |
| Routes of administration | By mouth |
| Drug class | Estrogen; Progestin; Progestogen |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
See also
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.